cell therapy

embryonic stem cells

Biotech

Cell therapy biotech keeps adapting, selling 4 programs for $55M

USWM plans on offering jobs to about half of Adaptimmune’s workforce. As of Dec. 31, 2024, the biotech had 506 employees.

Gabrielle Masson Jul 28, 2025 10:52am

red and yellow background with scissors

Cell therapy biotech Adicet sheds 30% of staffers

Jul 24, 2025 10:20am

Graphic image of a red thumbs down against a blue background

FDA rejects Capricor’s DMD cell therapy, asks for more data

Jul 11, 2025 9:18am

ice skate on the ice

Minovia skates SPAC-wards into public market

Jun 25, 2025 10:33am

Reorganization team change restructure

Industry disappointed as FDA reportedly puts Verdun on leave

Jun 20, 2025 1:53am

Businessman about to be crushed by falling dominos

Fierce Pharma

BioNTech to wind down cell therapy manufacturing in Maryland

Jun 18, 2025 10:23am